2008 Washington Orthopedic Summit
2008 Washington Orthopedic Summit
Musculoskeletal Conditions:
Unusual, benign and malignant.
Tips and innovations from the experts
When: Saturday, September 6 - Monday, September 8, 2008
Where: Hilton Alexandria Old Town
Agenda
Saturday: Musculoskeletal Science
Sunday: Musculoskeletal Pathology
Monday: Musculoskeletal Bioengineering
*Seperate one day registration available for Monday!
View full agenda
Course Director: Felasfa M.Wodajo, MD
View faculty
Registration
Register online or contact Heather McCloskey, CME
department, Inova Fairfax Hospital, (703) 776-3959 for additional information.
The Inova Office of Continuing Medical Education is accredited by the
Medical Society of Virginia to sponsor continuing medical education for
physicians. The Inova Office of Continuing Medical Education designates this
educational activity for a maximum of 16 AMA PRA Category 1 credits.
Physicians should only claim credit commensurate with the extent of their participation
of the activity.
The Challenges
Orthopedic surgeons and radiologists often encounter bone and soft tissue tumors outside their usual frame of expertise. This Orthopedic Summit combines robust information on clinical, radiologic and pathologic characteristics of tumors in fast-paced, applicable way.
The field of Orthopedics is facing a new and rapid evolution as advances in stem cell research and material sciences ("tissue engineering") enter clinical practice. One day of this three day course will be dedicated to a detailed introduction of these advances.
Course Content
I. Musculoskeletal Science
This day will addresses inflammatory and metabolic and genetic skeletal disorders. Examples of these conditions include psoriatic arthritis, lupus, hyperparathyroidism, osteomalacia and neurofibromatosis. These are conditions commonly seen by orthopedic surgeons and radiologists but often not immediately recognized due to lack of experience or understanding of the basic disease processes. Again, a tightly organized multidisciplinary approach will be led by a clinician, radiologist and pathologist each discussing his or her perspective on the conditions. There is no alternative on-going educational opportunity in our medical community to address these educational needs, nor to help trainees prepare for examinations or physicians preparing for re-certification.
II. Musculoskeletal Pathology
Most practicing orthopedic surgeons and radiologists see very few primary bone and soft tissue tumors and are uncomfortable differentiating benign from malignant lesions. They are not sure when and if to refer such lesions for sub-specialty care. This portion of the course will provide them a framework for making broad distinctions between the various types of bone and soft tissue tumors and allow them to make more accurate and targeted referrals. This section of the course also seeks to reduce the chances of inadvertent surgery on tumors and inappropriate biopsy, both of which can affect outcome negatively.
Each tumor is presented in a multidisciplinary fashion by a clinician, radiologist and pathologist discussing the tumor from their perspective. Thus, by correlating the clinical presentation with the imaging and microscopic findings, this segment of the course becomes valuable for orthopedists, radiologists as well as pathologists. Furthermore, this topic, together with Monday's Musculoskeletal Science program, covers a large percentage of questions on the orthopedic examinations and is thus of keen interest to trainees.
III. Orthopedic Bioengineering
This special day is dedicated to Orthopedic Bioengineering and is specifically tailored for Orthopedic Surgeons. Separate one-day registration is available for Monday's program. Rapid advances in stem cell biology and material sciences promise that the future treatment of injury and tissue loss will be very different and more biologically appropriate than current practices. This will certainly apply to musculoskeletal tissues and much of the research being performed today in orthopedics is directed toward the promise of cell based tissue engineering.
Thus, the final day of the course will bring together orthopedic surgeons, biologists and engineers, all actively involved in the field of orthopedic bioengineering to collectively educate registrants about the current state of the art as well as future horizons in bone, soft tissue and cartilage bioengineering. The day will culminate in a panel discussion that will include a clinician, a researcher and industry representatives discussing the challenge of translating research into commercially viable products.
Surgeons will find this day's program particularly valuable in light of the current accelerated pace of research developments in an environment in which there are few on-going educational programs available to explain the clinical, biologic and engineering aspects of this research. Furthermore, orthopedic commercial entities are now bringing many products to market with promises of rapid bone and soft tissue regeneration. These products are uniformly expensive but unfortunately not as uniformly effective. Without an understanding of the principles underpinning regenerative medicine, clinicians will remain unequipped to make appropriate product and usage decisions.
Target Audience
This course will be of great value to orthopedic, radiology and pathology physicians, attendings and residents.
Furthermore, "Orthopedic Science", including genetics, pathology, bone and cartilage biology, accounts for a large and increasing percentage of questions on Orthopedic In-Training and Board exams, and thus this review should be of keen interest to trainees.
